Updated Jul 16, 2026
Dahlquist Karl S. has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Karl S. Dahlquist serves as the Chief Legal Officer at AtriCure, Inc., a company specializing in surgical treatments for atrial fibrillation and related conditions. He has been involved in the legal aspects of the company's operations, contributing to its compliance and regulatory strategies.
| Role | Chief Legal Officer |
|---|---|
| Notability | 30/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-02 | ATRC | AtriCure, Inc. | A — Grant or award | 636 | $23.78 | $15K |
| 2026-03-03 | ATRC | AtriCure, Inc. | F — Tax withholding / forfeiture | 15.7K | $31.26 | $490K |
| 2026-03-03 | ATRC | AtriCure, Inc. | A — Grant or award | 15.2K | $0.00 | |
| 2026-03-03 | ATRC | AtriCure, Inc. | A — Grant or award | 28.0K | $0.00 | |
| 2025-06-30 | ATRC | AtriCure, Inc. | A — Grant or award | 822 | $25.84 | $21K |
Karl S. Dahlquist serves as the Chief Legal Officer at AtriCure, Inc., a company specializing in surgical treatments for atrial fibrillation and related conditions. He has been involved in the legal aspects of the company's operations, contributing to its compliance and regulatory strategies.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Dahlquist Karl S. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.